Arrowhead Research ARWR Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $107.88M.
The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arrowhead Research's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arrowhead Research's total debt?
- Arrowhead Research (ARWR) reported total debt of $107.88M in Q1 2026.
- How has Arrowhead Research's total debt changed year-over-year?
- Arrowhead Research's total debt decreased by 5.6% year-over-year, from $114.31M to $107.88M.
- What is the long-term trend for Arrowhead Research's total debt?
- Over 5 years (2020 to 2025), Arrowhead Research's total debt has grown at a 39.4% compound annual growth rate (CAGR), from $21.14M to $111.4M.
- What does total debt mean?
- The total amount of money the company owes to lenders and financial institutions.
- How do you interpret total debt?
- An increase in total debt suggests higher financial leverage and increased interest expense, which may be necessary for funding R&D but raises solvency risk. A decrease indicates deleveraging, potentially improving the balance sheet strength and reducing interest burdens.
- How does total debt compare across companies?
- In the biotechnology sector, debt levels vary significantly based on the stage of the drug development pipeline; early-stage firms often maintain lower debt to avoid interest strain, while mature firms may use debt to scale commercial operations.